Literature DB >> 16531603

Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study.

Peter J Zed1, Riyad B Abu-Laban, David W Harrison.   

Abstract

OBJECTIVES: To describe and analyze the intubating conditions and hemodynamic effects of etomidate in patients undergoing rapid sequence intubation (RSI) in the emergency department.
METHODS: The authors conducted a prospective observational study of all patients who received etomidate for induction of RSI over a 42-month period in a large tertiary care teaching hospital. Intubating conditions were determined by the emergency physician for both sedation and paralysis and for technical difficulty using a five-point Likert scale. Hemodynamic effects were evaluated before, after, and every five minutes for 15 minutes following administration of etomidate.
RESULTS: Etomidate was used for induction of RSI in 522 patients, all of whom were included in the final efficacy analysis, while 491 were included in the analysis of hemodynamics. Lidocaine and fentanyl were used as pretreatment in 65.1% and 26.1% of patients, respectively, while succinylcholine was the paralytic in 94.3% of intubations. Sedation and paralysis were rated as excellent or good in 88.1% and 8.8% of patients, respectively, while technical difficulty was very easy or easy in 60.7% and 19.0% of patients, respectively. Mean (+/- SD) baseline systolic blood pressure (sBP), diastolic blood pressure (dBP), and heart rate were found to be 132.7 (+/- 35.4) mm Hg, 69.5 (+/- 21.2) mm Hg, and 96.1 (+/- 26.2) bpm, respectively. Overall, there was a clinically insignificant elevation in sBP (p < 0.0001), dBP (p = 0.0002), and heart rate (p < 0.0001) immediately postintubation. Elevations in sBP persisted at five minutes (p = 0.0230) and ten minutes (p = 0.0254) postintubation. Diastolic blood pressure and heart rate returned to baseline at five minutes after intubation and remained stable throughout the 15-minute postintubation assessment period. In the subgroup of 80 patients with a preintubation sBP < 100 mm Hg, there was a 12.1-mm Hg elevation in sBP (p < 0.0001) and a 7.3-mm Hg elevation in dBP (p = 0.0001) immediately postintubation. This elevation persisted throughout the 15-minute postintubation assessment period.
CONCLUSIONS: Etomidate appears to provide appropriate intubating conditions in a heterogeneous group of patients undergoing RSI in the emergency department. Hemodynamic stability appears to be present following administration of this agent, even in patients with low pre-RSI blood pressure. This attribute must be weighed against potential adverse effects of this agent, including adrenal suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531603     DOI: 10.1197/j.aem.2005.11.076

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  18 in total

1.  Managing the difficult airway in craniomaxillofacial trauma.

Authors:  Richard Lock
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2010-09

2.  Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.

Authors:  Ervin Pejo; Yan Feng; Wei Chao; Joseph F Cotten; Ri Le Ge; Douglas E Raines
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

Review 3.  Collective Review of the Status of Rapid Sequence Intubation Drugs of Choice in Trauma in Low- and Middle-Income Settings (Prehospital, Emergency Department and Operating Room Setting).

Authors:  Leressè Pillay; Timothy Hardcastle
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

4.  In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.

Authors:  Ervin Pejo; Joseph F Cotten; Elizabeth W Kelly; Ri Le Ge; Gregory D Cuny; Joydev K Laha; Jifeng Liu; Xiang Jie Lin; Douglas E Raines
Journal:  Anesth Analg       Date:  2011-09-29       Impact factor: 5.108

5.  Etomidate use in severe sepsis and septic shock patients does not contribute to mortality.

Authors:  Robert Ehrman; Charles Wira; Afsaneh Lomax; Alison Hayward; Jean Marcelin; Thomas Ellis; Karin Przyklenk; Gregory Volturo; Marie Mullen
Journal:  Intern Emerg Med       Date:  2011-03-11       Impact factor: 3.397

6.  Tips to Improve Success Rate of Intubation: A Standardized Rapid Sequence Intubation Protocol Attached to the Resuscitation Cart.

Authors:  Shih-Hao Lin; Chih-Hsien Chi; Chia-Chang Chuang; Tsung-Yu Chan
Journal:  J Acute Med       Date:  2017-06-01

7.  Etomidate, adrenal function, and mortality in critically ill patients.

Authors:  Jacob E Sunshine; Steven Deem; Noel S Weiss; N David Yanez; Stephen Daniel; Katherine Keech; Marcia Brown; Miriam M Treggiari
Journal:  Respir Care       Date:  2013-04       Impact factor: 2.258

8.  Etomidate for intubation of patients who have sepsis or septic shock--where do we go from here?

Authors:  Donald E G Griesdale
Journal:  Crit Care       Date:  2012-12-27       Impact factor: 9.097

Review 9.  Pro/con debate: Is etomidate safe in hemodynamically unstable critically ill patients?

Authors:  Gordon Flynn; Yahya Shehabi
Journal:  Crit Care       Date:  2012-07-19       Impact factor: 9.097

Review 10.  Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.

Authors:  Eric A Bruder; Ian M Ball; Stacy Ridi; William Pickett; Corinne Hohl
Journal:  Cochrane Database Syst Rev       Date:  2015-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.